Main menu

Oxford Nanopore initiates legal proceedings against Pacific Biosciences


On Friday 21st April 2017, Oxford Nanopore initiated its first legal proceedings in Europe against Pacific Biosciences* for infringement of EP1192453, which Oxford Nanopore has an exclusive right to commercialise under a license agreement with Harvard University.

This first suit was issued in the Patents Court of the High Court’s Chancery Division, UK.

Update 25th April: Oxford Nanopore has subsequently issued a second suit in Germany at the Mannheim Court.

*refers to Pacific Biosciences of California Inc and Pacific Biosciences Ltd (UK) in UK proceedings and Pacific Biosciences of California Inc in German proceedings.

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

お問い合わせ

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

Oxford Nanoporeについて

Contact us 経営陣 メディアリソース & お問い合わせ先 投資家向け Oxford Nanopore社で働く BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Japanese flag